Compare EZGO & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZGO | CCEL |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 32.7M |
| IPO Year | 2021 | 1997 |
| Metric | EZGO | CCEL |
|---|---|---|
| Price | $1.57 | $3.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 84.0K | 15.4K |
| Earning Date | 07-01-2025 | 02-27-2026 |
| Dividend Yield | N/A | ★ 11.98% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $20,486,067.00 | ★ $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.42 | N/A |
| 52 Week Low | $1.42 | $3.10 |
| 52 Week High | $17.24 | $8.79 |
| Indicator | EZGO | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 35.15 | 39.87 |
| Support Level | $1.70 | $3.25 |
| Resistance Level | $2.10 | $3.57 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 7.32 | 28.21 |
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.